Protocols for nonclinical laboratory
studies ( safety studies) are required under 21 CFR 58.120 for
approval of new animal drugs. Protocols for adequate and well -
control effectiveness studies are required under 21 CFR
514.117(b)The establishment of a process for acceptance of the
electronic submission of protocols for studies conducted by
sponsors in support of new animal drug applications is part of CVMs
ongoing initiative to provide a method for paperless
submissions.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.